Nuveen Insured CA Premium Incm Mncpl Fd2 NCL:NYQ 
| 12.69USD Last Price | +0.14 +1.12% Today's Change | 18.50k Shares Traded | 9.81-14.39 52 Week Range | +1.81 +16.64% 52 Week Change | -- Beta |
Nuveen Insured CA Premium Incm Mncpl Fd2 Summary
| Open | 12.58 | Average Volume | 22.67k | |
| Day High | 12.69 | EPS (TTM) | -- | |
| Day Low | 12.58 | Div PS (TTM) | 82.80USC | |
| Previous Close | 12.55 | Div Yield | 6.52% | |
| Shares Outstanding | 12.66m | Div Ex-Date | Feb 10 2010 | |
| Market Cap | -- | Div Pay-Date | Mar 01 2010 | |
| Free Float | -- | Next Div Ex-Date | -- | |
| P/E (TTM) | -- | Next Div Pay-Date | -- | |
As of last close on Feb 09 2010, Nuveen Insured CA Premium Incm Mncpl Fd2 (NCL:NYQ) closed at 12.69, 11.81% below its 52-week high of 14.39, set on September 22, 2009.
Comparative Analysis
Over the last week Nuveen Insured CA Premium Incm Mncpl Fd2 (NCL:NYQ) outperformed the Dow Jones Industrial Average index. Overall the relative performance against the index has been mixed.
| Name | 1 Week | 1 Month | 6 Month | 1 Year | 5 Year |
|---|---|---|---|---|---|
| Nuveen Insured CA Premium Incm Mncpl Fd2 NCL:NYQ | +0.48% | +0.79% | +2.26% | +16.64% | -15.51% |
| Dow Jones Industrial Average | -1.25% | -5.27% | +7.72% | +21.47% | -6.21% |
© Thomson Reuters Click for restrictions.
All markets data located on FT.com is subject to the FT Terms & Conditions.
All content on FT.com is for your general information and use only and is not intended to address your particular requirements.In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time".Share price information may be rounded up/down and therefore not entirely accurate.FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.